ANCA-ASSOCIATED GLOMERULONEPHRITIS

Clinical trials for ANCA-ASSOCIATED GLOMERULONEPHRITIS explained in plain language.

Never miss a new study

Get alerted when new ANCA-ASSOCIATED GLOMERULONEPHRITIS trials appear

Sign up with your email to follow new studies for ANCA-ASSOCIATED GLOMERULONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists test One-Time cell therapy to reset the immune system in devastating autoimmune conditions

Disease control Recruiting now

This early-stage study is testing a new, one-time cell therapy called RD06-05 for people with serious autoimmune diseases like lupus and vasculitis. The therapy, known as CAR-T, involves modifying a patient's own immune cells to target and remove the harmful cells causing the dis…

Matched conditions: ANCA-ASSOCIATED GLOMERULONEPHRITIS

Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

ANCA-ASSOCIATED GLOMERULONEPHRITIS

Get alerted when new ANCA-ASSOCIATED GLOMERULONEPHRITIS trials appear

Scientists test One-Time cell therapy to reset the immune system in devastating autoimmune conditions